Skip navigation
Agenda

Critical Updates on Pressing Issues Including Drug Pricing Oversight, Value-Based Frameworks and State Pricing Transparency

November 7-8, 2018
  • Baltimore, MD

Agenda

Want more agenda details? Download the brochure.

DAY ONE Wednesday, November 7, 2018

7:30

Registration and Continental Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Rafael Angulo
Director, Government Contracting,
Pricing and Analysis
Novartis

8:45

POLICY OUTLOOK Drug Pricing Update — Policy and Practice

John Shakow
Partner
King & Spalding

9:30

Statutory Requirements and Changes around Drug Pricing Pressures

Rujul Desai
Of Counsel
Covington & Burling

10:30

Networking and Refreshment Break

10:45

ENFORCEMENT ADDRESS Litigation and Investigations Impacting Government Contracting and Pricing

T. Reed Stephens
Partner
McDermott Will & Emery LLP

11:45

Evaluate the Current State of the 340B Regulatory Outlook

Amanda Bartelme
Director, Reimbursement, U.S. Policy
GSK

12:30

Networking Luncheon

1:30

340B Analytics and Duplicate Discount Prevention

Raquel Villanueva
Senior Manager, Contract Operations
Jazz Pharmaceuticals

Kwame Bonsu
Manager, Pricing, Contracting and Reimbursement
Jazz Pharmaceuticals

2:15

Value-Based Contracting and Government Pricing Considerations

Meena Datta
Partner
Sidley Austin LLP

3:00

Networking and Refreshment Break

3:30

PANEL DISCUSSIONDocumentation and Reasonable Assumptions

Stephen E. Ruscus
Partner
Morgan, Lewis & Bockius LLP

Rafael Angulo
Director, Government Contracting,
Pricing and Analysis
Novartis

4:15

INTERACTIVE TABLE TALKS

During this collaborative and engaging session, benefit from the opportunity to break into focused groups to engage, share insights and benchmark with peers. The end of the session includes a comprehensive wrap-up of salient points.

I. Generic Pricing and Contracting

FACILITATOR:

Sam Woronof
Principal Consultant
Activus GPS

II. Price Change Considerations

FACILITATOR:

Constance Wilkinson
Member
Epstein Becker Green

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO Thursday, November 8, 2018

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Rafael Angulo
Director, Government Contracting,
Pricing and Analysis
Novartis

8:45

State Drug Pricing Transparency Update

Angela Marcucci
Director, Global Public and Government Affairs
DBV Technologies

9:30

Product Acquisition – Pre and Post Deal Considerations

Chris Cobourn
Managing Director
KPMG

10:15

Networking and Refreshment Break

10:45

The Impact of the Changing Customer Landscape on Pricing and Price Reporting

Trevor Wear
Partner
Sidley Austin LLP

11:30

Strategies to Ensure Drug Categorization Accuracy in DDR

Catrina Hirschauer
Manager, Government Reporting
Upsher-Smith Laboratories, LLC

12:15

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE Wednesday, November 7, 2018

7:30

Registration and Continental Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Rafael Angulo
Director, Government Contracting,
Pricing and Analysis
Novartis

8:45

POLICY OUTLOOK Drug Pricing Update — Policy and Practice

John Shakow
Partner
King & Spalding

9:30

Statutory Requirements and Changes around Drug Pricing Pressures

Rujul Desai
Of Counsel
Covington & Burling

10:30

Networking and Refreshment Break

10:45

ENFORCEMENT ADDRESS Litigation and Investigations Impacting Government Contracting and Pricing

T. Reed Stephens
Partner
McDermott Will & Emery LLP

11:45

Evaluate the Current State of the 340B Regulatory Outlook

Amanda Bartelme
Director, Reimbursement, U.S. Policy
GSK

12:30

Networking Luncheon

1:30

340B Analytics and Duplicate Discount Prevention

Raquel Villanueva
Senior Manager, Contract Operations
Jazz Pharmaceuticals

Kwame Bonsu
Manager, Pricing, Contracting and Reimbursement
Jazz Pharmaceuticals

2:15

Value-Based Contracting and Government Pricing Considerations

Meena Datta
Partner
Sidley Austin LLP

3:00

Networking and Refreshment Break

3:30

PANEL DISCUSSIONDocumentation and Reasonable Assumptions

Stephen E. Ruscus
Partner
Morgan, Lewis & Bockius LLP

Rafael Angulo
Director, Government Contracting,
Pricing and Analysis
Novartis

4:15

INTERACTIVE TABLE TALKS

During this collaborative and engaging session, benefit from the opportunity to break into focused groups to engage, share insights and benchmark with peers. The end of the session includes a comprehensive wrap-up of salient points.

I. Generic Pricing and Contracting

FACILITATOR:

Sam Woronof
Principal Consultant
Activus GPS

II. Price Change Considerations

FACILITATOR:

Constance Wilkinson
Member
Epstein Becker Green

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO Thursday, November 8, 2018

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Rafael Angulo
Director, Government Contracting,
Pricing and Analysis
Novartis

8:45

State Drug Pricing Transparency Update

Angela Marcucci
Director, Global Public and Government Affairs
DBV Technologies

9:30

Product Acquisition – Pre and Post Deal Considerations

Chris Cobourn
Managing Director
KPMG

10:15

Networking and Refreshment Break

10:45

The Impact of the Changing Customer Landscape on Pricing and Price Reporting

Trevor Wear
Partner
Sidley Austin LLP

11:30

Strategies to Ensure Drug Categorization Accuracy in DDR

Catrina Hirschauer
Manager, Government Reporting
Upsher-Smith Laboratories, LLC

12:15

Close of Conference